Woosley Raymond L. 4
4 · ARCA biopharma, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Woosley Raymond L.
Director
Transactions
- Award
Stock Option (right to buy)
2022-12-15+6,000→ 6,000 totalExercise: $2.32Exp: 2032-12-15→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of December 15, 2022. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.